- Investing Ideas
- Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
3
0 new
Mid-Large Cap Stocks
3 companies
Financière de Tubize
Market Cap: €9.1b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€203.60
7D
-1.2%
1Y
48.0%
UCB
Market Cap: €45.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€238.00
7D
1.0%
1Y
37.3%
argenx
Market Cap: €47.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€753.60
7D
-0.8%
1Y
56.0%